Employers are key to transforming healthcare by creating competitive, cost-effective networks independent of federal policy ...

A panelist discusses how the historical standard of care for metastatic squamous cell anal carcinoma evolved from ...

A panelist discusses how squamous cell cancer of the anal canal has nearly doubled in incidence over 30 years, with human ...

As sweeping policy shifts and rising restrictions threaten LGBTQ+ health access, providers, payers and employers reflect on what’s at stake in Pride Month's end—and what it will take to protect ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

Of the 102,166 GLP-1s analyzed, 94% had some form of commercial insurance, yet cost-saving options were still widely overlooked.

Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...

A new study finds that enrollees who had difficulty accessing care in Medicare Advantage plans were more likely to switch to ...

This latest data is a change from previous survey answers, in which 71% of healthcare leaders expected improved profitability ...

The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that ...

More than 50 insurers have pledged to streamline and simplify the prior authorization process through six new commitments.